AN2 Therapeutics, Inc. (ANTX) — Stock Score Summary

AN2 Therapeutics, Inc. (ANTX) has a MoatMap StockRank of 32/100 based on Quality (29/100), Value (30/100), and Momentum (59/100) factor scores. The current signal is SELL. AN2 Therapeutics is a clinical-stage biopharmaceutical company with high binary risk, no current revenues, and no alignment with our structural macro themes.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for serious infectious diseases, with a primary focus on difficult-to-treat non-tuberculous mycobacteria (NTM) infections. The company's competitive edge lies in its novel drug candidates targeting unmet medical needs, leveraging deep scientific expertise to advance its pipeline.

Key Financial Metrics

Price$3.91
Market Cap$161M
P/E (Forward)-4.01
Price/Book1.84
Return on Equity-44.6%
Return on Invested Capital-71.6%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-19M

AN2 Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is AN2 Therapeutics, Inc.’s (ANTX) StockRank?
MoatMap’s StockRank for AN2 Therapeutics, Inc. (ANTX) is 32/100, with a Sell signal. It is a composite of Quality (29), Value (30), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does AN2 Therapeutics, Inc. have an economic moat?
AN2 Therapeutics, Inc. (ANTX) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AN2 Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for AN2 Therapeutics, Inc. (ANTX) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AN2 Therapeutics, Inc. in?
AN2 Therapeutics, Inc. (ANTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANTX deep dive reportAI ChampionsHow we score stocksSense-check another stock